Palatin Technologies (PTN) Return on Invested Capital (2017 - 2024)
Palatin Technologies' (PTN) quarterly Return on Invested Capital came in at 1.57% in Q2 2024, down 35.47% on a QoQ basis from 1.16% in Q1 2024.
Palatin Technologies (PTN) Return on Invested Capital (2017 - 2024) Analysis & Trends
Palatin Technologies (PTN) has 4 years of Return on Invested Capital data on file, last reported at 1.57% in Q2 2024.
- Quarterly Return on Invested Capital changed N/A year-over-year to 1.57% in Q2 2024, while the trailing twelve-month figure through Jun 2024 was 1.57% (changed N/A YoY) and the FY2017 annual result came in at 9.22%, changed N/A from the prior year.
- Return on Invested Capital slipped to 1.57% in Q2 2024, from 1.16% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 1.16% in Q1 2024 to a low of 1.57% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Palatin Technologies | 40.37 Mn | 40.37 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -1.57% |
| Mar 31, 2024 | -1.16% |
| Dec 31, 2023 | -1.29% |
| Mar 31, 2018 | 43.07% |
| Dec 31, 2017 | 41.22% |
| Sep 30, 2017 | 32.35% |
| Jun 30, 2017 | 9.61% |